CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-14 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 280,000 | ||
| 2024-03-13 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 212,370 |
| 2024-03-13 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $44.67 | $782K | 194,870 |
| 2024-03-13 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 297,500 | ||
| 2024-03-11 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −7,874 | $44.71 | $352K | 949 |
| 2024-03-08 | Flynn Sean C. SVP, General Counsel | Sale 10b5-1 | −8,115 | $45.33 | $368K | 167 |
| 2024-03-08 | Flynn Sean C. SVP, General Counsel | Sale | −8,115 | $45.33 | $368K | 167 |
| 2024-03-07 | SIEGAL JONATHAN Principal Accounting Officer | Sale | −1,634 | $45.00 | $74K | 1,400 |
| 2024-02-22 | Colangelo Dominick President and CEO | Grant or award · Stock Option (Right to Buy) | +182,500 | 182,500 | ||
| 2024-02-22 | Colangelo Dominick President and CEO | Grant or award · Restricted Stock Unit | +73,000 | 73,000 | ||
| 2024-02-22 | Flynn Sean C. SVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-02-22 | Flynn Sean C. SVP, General Counsel | Grant or award · Restricted Stock Unit | +12,000 | 12,000 | ||
| 2024-02-22 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +46,250 | 46,250 | ||
| 2024-02-22 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Restricted Stock Unit | +18,500 | 18,500 | ||
| 2024-02-22 | Halpin Michael Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2024-02-22 | Halpin Michael Chief Operating Officer | Grant or award · Restricted Stock Unit | +21,000 | 21,000 | ||
| 2024-02-22 | SIEGAL JONATHAN Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2024-02-22 | SIEGAL JONATHAN Principal Accounting Officer | Grant or award · Restricted Stock Unit | +7,500 | 7,500 | ||
| 2024-02-22 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-02-22 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Restricted Stock Unit | +12,000 | 12,000 |
Page 29 of 75 · 1,497 trades